AU Patent

AU2013201061B2 — Methods for synthesizing molybdopterin precursor z derivatives

Assigned to Alexion Pharma International SARL · Expires 2015-04-02 · 11y expired

What this patent protects

Provided herein are synthetic methods for preparing a compound of formula (I): HN P=O H2N N N 0 H H H Also provided herein are synthetic methods for preparing a compound of formula (XIII): HN P = 'N- 0 (XII H2 N =N O H A H The disclosure also provides useful intermediates, deriva…

USPTO Abstract

Provided herein are synthetic methods for preparing a compound of formula (I): HN P=O H2N N N 0 H H H Also provided herein are synthetic methods for preparing a compound of formula (XIII): HN P = 'N- 0 (XII H2 N =N O H A H The disclosure also provides useful intermediates, derivatives, prodrugs, and pharmaceutically acceptable salts, solvates and hydrates of the formula (I) and formula (XIII) compounds. These compounds are useful for treating diseases associated with molybdenum cofactor deficiency.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013201061B2
Jurisdiction
AU
Classification
Expires
2015-04-02
Drug substance claim
No
Drug product claim
No
Assignee
Alexion Pharma International SARL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.